Literature DB >> 28823370

Interaction between insulin-like growth factor binding protein-related protein 1 and transforming growth factor beta 1 in primary hepatic stellate cells.

Xiu-Qing Li1, Qian-Qian Zhang2, Hai-Yan Zhang2, Xiao-Hong Guo2, Hui-Qin Fan2, Li-Xin Liu3.   

Abstract

BACKGROUND: We previously showed that insulin-like growth factor binding protein-related protein 1 (IGFBPrP1) is a novel mediator in liver fibrosis. Transforming growth factor beta 1 (TGFβ1) is known as the strongest effector of liver fibrosis. Therefore, we aimed to investigate the detailed interaction between IGFBPrP1 and TGFβ1 in primary hepatic stellate cells (HSCs).
METHODS: We overexpressed TGFβ1 or IGFBPrP1 and inhibited TGFβ1 expression in primary HSCs for 6, 12, 24, 48, 72, and 96 hours to investigate their interaction and observe the accompanying expressions of α-smooth muscle actin (α-SMA), collagen I, fibronectin, and phosphorylated-mothers against decapentaplegic homolog 2/3 (p-Smad2/3).
RESULTS: We found that the adenovirus vector encoding the TGFβ1 gene (AdTGFβ1) induced IGFBPrP1 expression while that of α-SMA, collagen I, fibronectin, and TGFβ1 increased gradually. Concomitantly, AdIGFBPrP1 upregulated TGFβ1, α-SMA, collagen I, fibronectin, and p-Smad2/3 in a time-dependent manner while IGFBPrP1 expression was decreased at 96 hours. Inhibition of TGFβ1 expression reduced the IGFBPrP1-stimulated expression of α-SMA, collagen I, fibronectin, and p-Smad2/3.
CONCLUSIONS: These findings for the first time suggest the existence of a possible mutually regulation between IGFBPrP1 and TGFβ1, which likely accelerates liver fibrosis progression. Furthermore, IGFBPrP1 likely participates in liver fibrosis in a TGFβ1-depedent manner, and may act as an upstream regulatory factor of TGFβ1 in the Smad pathway.
Copyright © 2017 The Editorial Board of Hepatobiliary & Pancreatic Diseases International. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Smad pathway; extracellular matrix; insulin-like growth factor binding protein-related protein 1; primary hepatic stellate cells; transforming growth factor β1; α-smooth muscle actin

Mesh:

Substances:

Year:  2017        PMID: 28823370     DOI: 10.1016/S1499-3872(17)60013-4

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  5 in total

1.  IGFBP-6/sonic hedgehog/TLR4 signalling axis drives bone marrow fibrotic transformation in primary myelofibrosis.

Authors:  Lucia Longhitano; Daniele Tibullo; Nunzio Vicario; Cesarina Giallongo; Enrico La Spina; Alessandra Romano; Sofia Lombardo; Marina Moretti; Francesco Masia; Anna Rita Daniela Coda; Santina Venuto; Paolo Fontana; Rosalba Parenti; Giovanni Li Volti; Michelino Di Rosa; Giuseppe A Palumbo; Arcangelo Liso
Journal:  Aging (Albany NY)       Date:  2021-12-14       Impact factor: 5.682

2.  IGFBP7 remodels the tumor microenvironment of esophageal squamous cell carcinoma by activating the TGFβ1/SMAD signaling pathway.

Authors:  Xiuqing Li; Ji Zhang; Youshan Wu; Chuntao Ma; Dongying Wei; Lijuan Pan; Liangliang Cai
Journal:  Oncol Lett       Date:  2022-06-10       Impact factor: 3.111

3.  Insulin-Like Growth Factor Binding Protein-Related Protein 1 Activates Primary Hepatic Stellate Cells via Autophagy Regulated by the PI3K/Akt/mTOR Signaling Pathway.

Authors:  Yuzheng Zhou; Qianqian Zhang; Yangyang Kong; Xiaohong Guo; Haiyan Zhang; Huiqin Fan; Lixin Liu
Journal:  Dig Dis Sci       Date:  2019-08-29       Impact factor: 3.199

4.  Role of long non‑coding RNAs and related epigenetic mechanisms in liver fibrosis (Review).

Authors:  Niladri Ganguly; Subrata Chakrabarti
Journal:  Int J Mol Med       Date:  2021-01-26       Impact factor: 4.101

Review 5.  The Roles and Mechanisms of lncRNAs in Liver Fibrosis.

Authors:  Zhi He; Deying Yang; Xiaolan Fan; Mingwang Zhang; Yan Li; Xiaobin Gu; Mingyao Yang
Journal:  Int J Mol Sci       Date:  2020-02-21       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.